ASXL2 and acute myeloid leukemia: In fact, we now know that mutations inASXL1,ASXL2,TET2,DNMT3A, andIDH1/2 occur more commonly in MDS and AML than do chromosomal translocations, which also target key transcription factors and epigenetic regulators.